A panel discussion on the risks of hereditary cancer and the genetic testing options available will take place later this month at the Oshman Family JCC in Palo Alto.
Panelists will include Stanford University School of Medicine professor and researcher Dr. Allison Kurian and genetic counselor Julie Mak of UCSF Medical Center. Attendees will have an opportunity for a genetic screen for the breast cancer gene.
With one in 40 Ashkenazi Jews carrying an altered BRCA1 or BRCA2 gene, the risk of developing breast cancer or ovarian cancer is statistically higher in Jewish women than in the general population. There is also an elevated risk of developing other cancers such as pancreatic, prostate and skin cancer.
The panel discussion takes place at 7 p.m. Sept. 26 at the OFJCC, 3921 Fabian Way, Palo Alto. Admission is free. For information, contact (650) 223-8700 or www.paloaltojcc.org.